Alport syndrome is an inherited condition that affects the kidneys and can also affect hearing and vision. It develops because changes in certain genes disrupt type IV collagen, a protein that helps provide strength and support to the kidney’s filtering membranes and other tissues.
Alport syndrome often causes blood in the urine, sometimes beginning in childhood. Over time, some people develop increasing protein in the urine and declining kidney function. Hearing loss and specific eye changes may also occur, but not everyone develops all three problems, and the rate of progression varies considerably.
Early diagnosis matters because regular monitoring, appropriate treatment, and genetic counseling can help manage the condition and inform family planning.
What causes Alport syndrome?
Alport syndrome is caused by disease-causing variants (changes) in one of three genes: COL4A3, COL4A4, or COL4A5. These genes provide instructions for making type IV collagen, an important structural protein.
Type IV collagen forms part of the basement membrane, a thin supporting layer found in several tissues. In the kidneys, it helps the glomeruli—the tiny filtering units—keep blood cells and most proteins in the bloodstream while allowing waste and excess water to pass into urine.
When type IV collagen does not form or function properly, the kidney’s filtering membrane becomes abnormal. This can allow blood and protein to leak into urine and may eventually lead to scarring and reduced kidney function.
Alport syndrome is genetic, not contagious. It is not caused by eating particular foods, ordinary infections, or lifestyle choices.
How is Alport syndrome inherited?
The inheritance pattern helps explain why the condition can affect family members differently.
- X-linked Alport syndrome: Caused by variants in COL4A5. It is often more severe in males, although females can also develop significant kidney disease and hearing loss.
- Autosomal recessive Alport syndrome: Caused by disease-causing variants in both copies of COL4A3 or COL4A4. Kidney disease can progress significantly in affected individuals.
- Autosomal dominant Alport syndrome: Caused by a disease-causing variant in one copy of COL4A3 or COL4A4. The course is variable, and some people develop only mild abnormalities while others experience progressive kidney disease.
The exact risk to relatives depends on the genetic variant and inheritance pattern. A genetic counselor can explain family-specific risks and testing options.
What are the symptoms of Alport syndrome?
Symptoms differ depending on the genetic variant, age, and disease severity. Some people have few symptoms for years, while others develop progressive kidney disease earlier in life.
1. Blood and protein in the urine
Blood in the urine (hematuria) is often the earliest sign. It may be visible, making urine pink, red, or brown, but more commonly it is detected only through a urine test.
As the condition progresses, albuminuria—an abnormal amount of the protein albumin in the urine—may develop. Persistent albuminuria can indicate damage to the kidney’s filtering barrier and is associated with a greater risk of declining kidney function.
A single abnormal urine test does not establish Alport syndrome. Exercise, infection, and other conditions can also cause temporary blood or protein in urine, so repeat testing and clinical assessment may be needed.
2. Progressive kidney disease
Over time, damage to the kidney’s filtering membranes can lead to scarring and chronic kidney disease (CKD).
Doctors monitor kidney function using:
- Serum creatinine: A waste product measured in the blood to help assess kidney function.
- eGFR: An estimate of how efficiently the kidneys filter blood.
- Urine albumin-to-creatinine ratio (UACR): A measurement of albumin in urine that helps assess kidney damage.
- Blood pressure: High blood pressure can worsen kidney damage and may also develop as kidney function declines.
Trends over months and years are more informative than a single result. A falling eGFR or rising urine albumin level deserves attention, but the rate of change and the overall clinical picture matter.
3. Hearing loss
Alport syndrome can affect the inner ear, causing sensorineural hearing loss, which occurs when sound signals are not transmitted normally through the inner ear or hearing nerve pathways.
Hearing loss often affects the ability to hear higher-pitched sounds first. It may become noticeable during childhood, adolescence, or adulthood, depending on the genetic form.
It is more common in males with X-linked disease and in people with autosomal recessive disease. It is less common in females with X-linked disease and people with a single disease-causing variant in COL4A3 or COL4A4.
Hearing tests can identify changes before they become obvious in everyday conversations.
4. Eye abnormalities
Some people develop eye changes associated with abnormal type IV collagen, including:
- Anterior lenticonus: An unusual cone-shaped bulging of the lens that can affect vision.
- Retinal changes: Alterations in the light-sensitive tissue at the back of the eye.
- Other lens abnormalities: These may affect visual clarity in some individuals.
Not everyone with Alport syndrome develops eye problems. An eye examination at diagnosis helps identify abnormalities that may need monitoring or treatment.
PMC
+1
How is Alport syndrome diagnosed?
Diagnosis usually combines medical history, urine and blood tests, genetic testing, and sometimes a kidney biopsy.
Genetic testing is a key diagnostic tool. Testing generally examines the COL4A3, COL4A4, and COL4A5 genes for disease-causing variants.
Other investigations may include:
- Urinalysis: Checks for blood and protein.
- Blood tests: Measure creatinine, estimate eGFR, and assess other aspects of kidney health.
- Hearing assessment: Detects sensorineural hearing loss.
- Eye examination: Looks for characteristic eye changes.
- Kidney biopsy: Examines a small sample of kidney tissue when the diagnosis remains uncertain or another kidney disease is suspected.
A biopsy is not always necessary when genetic testing and the clinical findings clearly establish the diagnosis. Conversely, finding a genetic variant does not automatically explain every kidney abnormality; some cases require further evaluation.
If Alport syndrome is suspected, a nephrologist can help coordinate testing. Genetic counseling is particularly useful when other family members may be affected.
PMC
+1
Can treatment slow kidney disease progression?
There is currently no established treatment that corrects the underlying genetic defect in routine clinical care. However, treatment can reduce stress on the kidneys and help delay disease progression.
Medicines that protect kidney function
ACE inhibitors, such as ramipril, and angiotensin receptor blockers (ARBs), such as losartan, are commonly used to reduce pressure within the kidney’s filtering system and lower urine protein.
These medicines are important because treatment may be beneficial before substantial loss of kidney function occurs. The timing of treatment depends on the genetic form, age, urine findings, and individual risk.
They can increase blood potassium and sometimes cause a rise in creatinine, so clinicians monitor blood pressure, kidney function, and electrolytes. A change in creatinine does not automatically mean permanent kidney damage.
For selected adults with proteinuria and CKD, a doctor may also consider an SGLT2 inhibitor. Evidence specifically in Alport syndrome is still developing, and suitability depends on the patient’s circumstances.
Everyday steps that support kidney health
- Monitor blood pressure and attend recommended kidney appointments.
- Complete urine albumin and kidney function tests as advised.
- Avoid frequent or unsupervised use of NSAID painkillers, such as ibuprofen, particularly if kidney function is reduced.
- Follow a balanced diet and avoid excessive salt intake; strict potassium or protein restriction is not necessary for everyone.
- Avoid unproven kidney supplements and detox products.
- Arrange hearing and eye assessments appropriate to the type of Alport syndrome.
These measures do not eliminate the genetic condition, but they can help manage its effects.
PMC
+1
Does Alport syndrome always lead to kidney failure?
No. The risk of kidney failure varies substantially between individuals. Some people maintain relatively stable kidney function for many years, while others develop advanced CKD and eventually need dialysis or a kidney transplant.
Important factors include:
- The gene involved and the specific variant.
- Whether one or both gene copies are affected.
- The amount and persistence of urine protein.
- Blood pressure control.
- The individual’s kidney function trend over time.
- How early appropriate treatment begins.
There is no single age by which kidney failure will occur. Family history can offer clues, but it cannot reliably predict an individual’s exact course.
If kidney failure develops, dialysis or transplantation can provide kidney replacement therapy. Alport syndrome does not usually recur in the transplanted kidney because the donor kidney has normal collagen genes, although rare transplant-related complications can occur.
What should family members do?
Because Alport syndrome is inherited, close relatives may benefit from evaluation even if they feel well.
Depending on the family mutation and inheritance pattern, a clinician may recommend:
- Urine testing for blood and protein.
- Blood pressure and kidney function checks.
- Targeted genetic testing for the known family variant.
- Genetic counseling before pregnancy or living kidney donation.
Living kidney donation requires particular caution in relatives who carry a disease-causing COL4A3, COL4A4, or COL4A5 variant. Their suitability must be assessed carefully by a specialist transplant team.
When should you seek medical attention?
Arrange a medical assessment if you have persistent blood in your urine, unexplained urine protein, a family history of Alport syndrome, or hearing loss alongside kidney abnormalities.
Seek urgent medical care for a marked reduction in urine output, severe shortness of breath, or sudden major swelling, especially if these occur with known kidney disease. Sudden hearing loss also requires urgent assessment because prompt treatment may improve the chance of recovery.
Bottom line
Alport syndrome is a genetic disorder caused by abnormalities in type IV collagen. It can lead to persistent blood in the urine, progressive kidney disease, hearing loss, and sometimes eye abnormalities, but the severity varies widely.
Early genetic diagnosis, regular monitoring, and appropriate kidney-protective treatment are central to care. If Alport syndrome is suspected, discussing urine testing, kidney function assessment, and genetic evaluation with a nephrologist is a sensible next step.
Further reading: The 2024 Alport syndrome clinical practice guideline, published in 2025, provides detailed recommendations on diagnosis, monitoring, and treatment.